INE205C01021
INE205C01021
POLY MEDICURE LTD.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 160.7B EUR | 170.99B EUR | 120.7B EUR | 179.94B EUR |
Enterprise Value | 156.34B EUR | 170.99B EUR | 123.72B EUR | 179.94B EUR |
Valuation Multiples | ||||
Trailing P/E | 51.04x | 54.49x | 37.61x | 70.33x |
Forward P/E | 32.4x | -- | -- | -- |
Price to Sales | 8.05x | 8.56x | 6.44x | 13.42x |
Price to Book | 5.17x | -- | 3.89x | -- |
EV/Revenue | 7.83x | 8.56x | 6.6x | 13.42x |
EV/EBITDA | 34.21x | 29.55x | 21.79x | 41.08x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |